TIP 63: Medications for Opioid Use Disorder
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
PCSS Resources for Health Professionals, Patients and Community
These resources for treating OUD and chronic pain were developed for health professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.
Essentials of Opioid Use Disorder: A Resource for Hepatologists and Infectious Disease Specialists Managing HCV and/or HIV Infection
Download this PDF guide outlining key information on identifying and treating opioid use disorder among patients with HIV and or HCV infection.
Clinical Mentoring for Treating OUD
The overarching goal of PCSS is to provide the most effective evidence-based clinical practices in preventing OUD through proper opioid prescribing practices, identifying patients with OUD, and the treatment of opioid use disorder.
HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
HHS’s guide on dosage reduction, tapering, or discontinuation of long-term opioid analgesics.
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update
The ASAM National Practice Guideline 2020 focused update is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with OUD. This is especially critical in the context of the ongoing COVID-19 emergency, which threatens to curtail patient access to evidence-based treatment.
Minnesota Opioid Prescribing Guidelines, First Edition 2018
These prescribing guidelines address opioid use throughout the pain continuum with a particular focus on the critical treatment period during acute pain and recovery from surgeries and injuries.
FDA issues warning for products marketed to treat opioid withdrawal
The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs.
CDC Opioid Prescribing Guidelines
This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care.
CDC Guidelines at a Glance
CDC guideline for prescribing opioids for chronic pain.